Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O M el-Agnaf

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Structural Biology|August 15, 2000
Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteinsO M El-Agnaf, G B Irvine
FEBS Letters|December 23, 1998
Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's diseaseO M El-Agnaf, R Jakes, M D Curran, et al.
Journal of Molecular Biology|June 23, 2001
Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrilsO M El-Agnaf, S Nagala, B P Patel, et al.
European Journal of Biochemistry|October 21, 1998
The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's beta-amyloid peptideO M El-Agnaf, D J Guthrie, D M Walsh, et al.
Biochemical and Biophysical Research Communications|July 13, 2000
Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's diseaseO M El-Agnaf, D S Mahil, B P Patel, et al.
Free Radical Biology & Medicine|May 23, 2001
New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-trapsS Turnbull, B J Tabner, O M El-Agnaf, et al.
European Journal of Biochemistry|December 16, 1998
The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrilsO M El-Agnaf, A M Bodles, D J Guthrie, et al.
Free Radical Biology & Medicine|May 23, 2001
alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitroS Turnbull, B J Tabner, O M El-Agnaf, et al.
The Biochemical Journal|November 20, 1998
Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)]O M El-Agnaf, G B Irvine, G Fitzpatrick, et al.
Biochemical and Biophysical Research Communications|July 5, 2001
Fluorescence anisotropy: a method for early detection of Alzheimer beta-peptide (Abeta) aggregationD Allsop, L Swanson, S Moore, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Structural Biology|August 15, 2000
Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteinsO M El-Agnaf, G B Irvine
FEBS Letters|December 23, 1998
Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's diseaseO M El-Agnaf, R Jakes, M D Curran, et al.
Journal of Molecular Biology|June 23, 2001
Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrilsO M El-Agnaf, S Nagala, B P Patel, et al.
European Journal of Biochemistry|October 21, 1998
The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's beta-amyloid peptideO M El-Agnaf, D J Guthrie, D M Walsh, et al.
Biochemical and Biophysical Research Communications|July 13, 2000
Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's diseaseO M El-Agnaf, D S Mahil, B P Patel, et al.
Free Radical Biology & Medicine|May 23, 2001
New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-trapsS Turnbull, B J Tabner, O M El-Agnaf, et al.
European Journal of Biochemistry|December 16, 1998
The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrilsO M El-Agnaf, A M Bodles, D J Guthrie, et al.
Free Radical Biology & Medicine|May 23, 2001
alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitroS Turnbull, B J Tabner, O M El-Agnaf, et al.
The Biochemical Journal|November 20, 1998
Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)]O M El-Agnaf, G B Irvine, G Fitzpatrick, et al.
Biochemical and Biophysical Research Communications|July 5, 2001
Fluorescence anisotropy: a method for early detection of Alzheimer beta-peptide (Abeta) aggregationD Allsop, L Swanson, S Moore, et al.
Pageof 2